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ticularly for those who are more accustomed
to Papanicolaou-stained material. Dr Cardozo
has always been a foremost advocate of the
use of Giemsa stain for cytological prepara-
tions, and most of the examples in the Atlas
are stained in this way. In this country
Papanicolaou's stain is in general use, even
when a Romanowski stain is also used for
some types of material. This difficulty should
not deter potential readers, who may find
themselves recognizing areas in which Giemsa
improves diagnostic accuracy.
The Atlas is profusely illustrated, with a
wide range of examples of benign and malig-
nant lesions, including a number of rare con-
ditions. The list of contents is detailed and
refers to the plates illustrating each con-
dition, making this a valuable bench book for
reference for those who use Giemsa stain;
some special stains are also illustrated. To
include 3300 coloured plates it has been
necessary to sacrifice the size of the pictures,
but this can be overcome by following the
author's advice and using a magnifying glass.
E. B. BUTLER
Pulmonary Metastasis. Eds L. WEISS and
H. A. GILBERT (1978). Boston: G. K. Hall
& Co. 336 pp. $34.50 (+15%0 outside US).
This book is the first of a projected series
of texts devoted to metastases at specific
sites. The first section deals with basic
mechanisms and pathways, and covers topics
such as the detachment of tumour cells, their
arrest in the circulation, models for micro-
metastases, and metastasis as an expression
of inherent tumour-cell heterogeneity. The
second part is concerned with patterns of
pulmonary metastasis viewed largely from a
pathological angle. The third section deals
with growth kinetics and the clinical manage-
ment of pulmonary metastases with particu-
lar reference to surgery and radiotherapy.
This bare outline indicates some general
characteristics of the book. The reader will
find an eclectic approach to pulmonary
metastasis, in which both clinical and experi-
mental aspects are skilfully presented. The
book provides an authoritative source of
recent work, and most readers will find a lot
of new material, as well as familiar material
set in new and interesting contexts. Certain
chapters are controversial, and the strong
emphasis on surgery is likely to provoke dis-
cussion. Curiouslylittle is saidabout palliative
treatment for pulmonary metastases.
Some of the contributions are a little
repetitive but, in general, this multidisci-
plinary approach to metastasis at one par-
ticular site has yielded an outstandingly
useful and interesting book. Its successors in
the series will be eagerly awaited.
R. L. CARTER
Mitomycin C. Current Status and De-
velopments. Eds S. K. CARTER and S. T.
CROOKE (1979). New York, San Francisco,
London: Academic Press. 254 pp. $20.00.
In his concluding remarks to this excellent
survey ofthe antitumour action ofMitomycin
C, Dr Carter points out that "an old drug can
always have a new lease of life". This agent
was recognized as an antitumour agent in the
late fifties and a considerable effort, especially
by Japanese investigators, has contributed to
a detailed knowledge of its mechanism of
action, to a programme of synthesizing
analogues and to the clinical testing both as
single agents and in combination with others.
This volume seeks to review all these aspects
in some detail.
The interesting opening chapter of S. T.
Crooke, entitled "Mitomycin C: An overview"
details its discovery and properties. This is
followed by a detailed and well written
account of the basic work that has been
undertaken to elucidate the mode of this
drug, by J. W. Lown. This chapter is an
invaluable component of the book, in that
the requirements for antitumour action in
this series of analogues have been concisely
and clearly documented and discussed at
the molecular level. The specialized multi-
pronged activity of the agent, involving
alkylation, cross-linking, hydroxyl radical
formation and its pH dependency are all
shown to be critically important to the quality
of its antitumour activity. Analogue de-
velopment is discussed by W. A. Remers,
together with their in vivo evaluation by
W. T. Bradner. This included some interesting
data on toxicity, especially in relation to
cisPDD. Ultrastructural changes due to
Mitomycin C are outlined by Y. Daskal and
S. T. Crooke, but the quality of the plates of
transmission electron microscopy is not
quite good enough to discern the nucleolar
segregation alluded to. A short and interestingBOOK REVIEWS
article on suppressor activity in the spleen of
mice, by B. F. Argyris, seems curiously
irrelevant to a book on Mitomycin C, as the
drug is not mentioned. The potentiation of
Mitomycin C activity by the DNA-repair
inhibitor, leucanthone, is described by
L. S. Koons and co-workers.
The remainder of the book gives detailed
summaries of the various clinical aspects of
the drug. The first on Acute Intermittent
Dose Scheduling (L. H. Baker and V. K.
Vaitkevicius) points out the advantage of
giving a series of short sharp shocks rather
than a single or continuous treatment. The
succeeding chapters deal separately with the
single agent and different combinations of
agents, including Mitomycin and Adriamycin
(R. L. Comis et al.) especially in advanced
breast cancer (L. R. Morgan) where carbo-
toxicity proves to be a problem. This could
be compared with a chapter on Mitomycin C
alone (T. E. Godfrey). Mitomycin alone and
in combination with Adriamycin and cyclo-
phosphamide are compared in advanced
adenocarcinoma of the lung (M. K. Samson
et al.) as a single agent in gastric cancer
(R. L. Comis), combinations of 5FU, Adria-
mycin and Mitomycin C are compared with
Streptomycin, Mitomycin C and 5FU, and of
these the first combination (FAM) proved to
be the most useful in the Phase II trials dis-
cussed (P. S. Schein et al.). Other chapters
include combination studies in gastric
carcinoma (P. J. Panettiere & L. Heilbrun), a
single-drug study with cervical cancer in the
U.S. (L. H. Baker), metastatic cervical cancer
with sequential Bleomycin and Mitomycin C
(T. Miyamoto), single agent in Head and
Neck cancer in Japan (Y. Inuyama), a com-
bination of Mitomycin C, 5FU and X-
radiation in squamous (epidermoid) cell
carcinoma of the anal canal, pre-operatively
(T. Buroker et al.), single agent in epidermoid
cancer of the lung (L. S. Koons et al.),
Mitomycin C instillation in bladder tumours
(T. Mishina & H. Watanabe) and multiple
superficial tumours of urinary bladder with
intravesical Mitomycin C (R. B. Braken &
D. Johnson), M. L. Gutierrez reviews the
use of Mitomycin C in childhood cancer, and
V. Ratanatharathorn et al. reviews the
nephrotoxic activity of Mitomycin C in
patients. Pulmonary toxicity (S. Mortino et
al.) and clinical pharmacology (S. D. Reich)
are discussed before the final summary
chapter by S. K. Carter, in which he con-
cludes that the agent is active in solid
tumours, with a broad spectrum, and offers
exciting potentials for combination study.
This book is a significant addition to the
library of both experimental and medical
oncologists.
B. W. Fox
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